CD99-positive soft tissue sarcoma with chromosomal translocation between 1 and 16 and inversion of chromosome 5

Oncology Letters

Volumn 3, Issue 6, 2012, Pages 1213-1215

  Kanamori, Masahiko ^a   Suzuki, Kayo ^a   Yasuda, Taketoshi ^a   Hori, Takeshi ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

CD99; Chromosome; Karyotype; Sarcoma

Indexed keywords

CD99 ANTIGEN; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; PROTEIN BCL 2; VIMENTIN; VINCRISTINE;

ADULT; ANGIOGRAPHY; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CHROMOSOME 5; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME INVERSION; CHROMOSOME TRANSLOCATION 1; CHROMOSOME TRANSLOCATION 16; FLEXOR MUSCLE; HISTOLOGY; HUMAN; HUMAN TISSUE; INGUINAL LYMPH NODE; KARYOTYPE 46,XY; LUNG METASTASIS; LYMPHADENOPATHY; MALE; NEEDLE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; RETROPERITONEAL CANCER; SEPTIC SHOCK; SOFT TISSUE SARCOMA; SPINDLE CELL; THIGH; TUMOR BIOPSY; TUMOR RECURRENCE; TUMOR VASCULARIZATION; TUMOR VOLUME;

EID: 84859456936     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2012.641     Document Type: Article

References (9)

1. Rocci A, Manara MC, Sciandra M, et al: CD99 inhibits neural differentiation of human Ewing sarcoma cells and thereby contributes to oncogenesis. J Clin Invest 120: 668-680, 2010.
2. Sandverg AA and Bridge JA: The Cytogenetics of Bone and Soft Tissue Tumors. RG Landes, Austin, pp288-312, 430-453, 1994.
3. Zucman J, Melot T, Desmaze C, et al: Combinational generation of variable fusion proteins in the Ewing family of tumors. EMBO J 12: 4481-4487, 1993.
4. Elias A, Ryan L, Sulkes A, et al: Response to mesna, doxorubicin, ifosfamide, and dacarbazine in 108 patients with metastatic or unresectable sarcoma and no prior chemotherapy. J Clin Oncol 7: 1208-1216, 1989.
5. Bridge JA, Sreekantaiah C, Mouron B, et al: Clonal chromosomal abnormalities in desmoid tumors: implications for histopathogenesis. Cancer 69: 430-436, 1992.
6. ISCN. An International System for Human Cytogenetic Nomenclature. Mitelman F (ed), Karger, Basel, 1995.
7. Guillou L, Benhattar J, Gengler C, et al: Translocation-positive low grade fibromyxoid sarcoma: clinicopathological and molecular analysis of a series expanding the morphologic spectrum and suggesting potential relationship to sclerosing epithelioid fibrosarcoma: a study from the French Sarcoma Group. Am J Surg Pathol 31: 1387-1402, 2007.
8. Malone VS, Dobin SM, Jones KA, et al: CD99-positive large cell neuroendocrine carcinoma with rearranged EWSR1 gene in an infant: a case of prognostically favorable tumor. Virchows Arch 457: 389-395, 2010.
9. Desmaze C, Brizard F, Turc-Carel C, et al: Multiple chromosomal mechanisms generate an EWS/ FLI1 or an EWS/ ERG fusion gene in Ewing tumors. Cancer Genet Cytogenet 97: 12-19, 1997.